Results 1 to 10 of about 80,519 (274)

A Comprehensive Approach to Myasthenia Gravis With Thymoma: A Case Report Highlighting Management of Myasthenic Crisis and Post-Crisis Care. [PDF]

Clin Case Rep
Abrar S, Ahmed ST, Khalil I, Hossain MI.
europepmc   +1 more source

Comparative study of Japanese nationwide epidemiological studies of myasthenia gravis using datasets of 2006 and 2018. [PDF]

PLoS One
Yoshikawa H, Adachi Y, Nakamura Y, Kuriyama N, Murai H, Nomura Y, Sakai Y, Iwasa K, Furukawa Y, Matsui M, Kuwabara S, Taskforce of Research that Aims to Contribute to Improving the Medical Level of Intractable Diseases and Neuroimmune Patients’ Quality of Life.   +11 more
europepmc   +1 more source

Perioperative Efgartigimod treatment for acute myasthenia gravis exacerbation with retroperitoneal mass: a case report. [PDF]

BMC Neurol
Yan J, Choi K, Fu P, Li Y, Li Z.
europepmc   +1 more source

Early-onset bull's eye maculopathy due to hydroxychloroquine in rheumatoid arthritis and myasthenia gravis. [PDF]

Int J Ophthalmol
Kasiri A, Feghhi M, Ansari A, Kasiri R, Mirdehghan MS, Mohammadi A, Kasiri MA.   +6 more
europepmc   +1 more source

Therapeutic strategies targeting complement in myasthenia gravis patients. [PDF]

J Neurol
Wang Y, Nao J, Duan Y, Li Z, Feng J.
europepmc   +1 more source

Myasthenia Gravis

New England Journal of Medicine, 2016
Myasthenia gravis is an autoimmune disease, which leads to load-dependent weakness of voluntary skeletal muscles with recovery of function after resting. The disease is caused by autoantibodies directed against the postsynaptic nicotinic acetylcholine receptors (AChR) leading to a reduction of neuromuscular transmission.
PRIOLA, adriano massimiliano, VELTRI, Andrea, PRIOLA, Sandro Massimo   +2 more
openaire   +9 more sources